Merck Sees Slightly More Success With External Rx Than Internal Candidates
Executive Summary
Merck has a slightly higher success rate with drug candidates developed through external licensing deals than with internally discovered compounds, Merck Senior Director-Strategic Research Initiatives, External Scientific Affairs Ronald Newbold said
You may also be interested in...
Merck To Sign 50 Business Development Deals In 2005
Merck's goal is to sign about 50 business development deals in 2005, the same level as 2004, the company said
Merck To Sign 50 Business Development Deals In 2005
Merck's goal is to sign about 50 business development deals in 2005, the same level as 2004, the company said
Merck To Increase Internal R&D But Reduce Outside Deals In 2005
Merck expects to decrease its spending on product acquisition and licensing deals in 2005, the company told analysts during its Dec. 14 annual business review in Whitehouse Station, N.J